Clinical Trials Directory

Trials / Completed

CompletedNCT07097610

The Effect of Mosaic Puzzle Game on Nomophobia in Adolescents

The Effect of Mosaic Puzzle Game on Nomophobia in Adolescents: A Randomised Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Rabia Nur TEKİ KESKİN · Academic / Other
Sex
All
Age
12 Years – 14 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the effect of mosaic puzzle application on nomophobia in middle school children aged 12-14. The data for the study will be collected over a 5-week period. The experimental group children will be asked to play mosaic puzzle games for 1 hour, 2 days a week for 5 weeks, at a time deemed appropriate by the school and under the supervision of the researcher. The control group children will not be given any intervention; they will only be observed, and a final test will be administered at the end of the 5 weeks. The study is planned as a single-center study, and a total of 30 children aged 12-14 with a nomophobia scale score of 60 or higher who meet the inclusion criteria will be included in the study. Hypothesis 1: The intervention group's level of nomophobia is lower than that of the control group.

Conditions

Interventions

TypeNameDescription
OTHERMosaic Puzzle InterventionThis study aims to investigate the effect of mosaic puzzle application on nomophobia in adolescents. The data for the study will be collected over a 5-week period. The experimental group children will be asked to play mosaic puzzle games for 1 hour, 2 days a week for 5 weeks at a time deemed appropriate by the school under the supervision of the researcher. The control group children will not be given any application; they will only be observed, and a final test will be administered at the end of the 5 weeks. The study is planned as a single-center study, and a total of 30 children aged 12-14 with a nomophobia scale score of 60 or higher who meet the inclusion criteria will be included in the study.

Timeline

Start date
2025-02-15
Primary completion
2025-03-15
Completion
2025-05-25
First posted
2025-07-31
Last updated
2025-07-31

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07097610. Inclusion in this directory is not an endorsement.